23 November 2022
Latham & Watkins Advises Imago BioSciences in Acquisition by Merck for US$1.35 Billion
Advising firms
Deal team
27 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Luke Bergstrom Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Benjamin Potter Lead | Latham & Watkins LLP | Partner | corporate | Bay Area |
| Max Schleusener | Latham & Watkins LLP | Partner | corporate | Chicago |
| Kevin Uhler | Latham & Watkins LLP | Associate | corporate | Chicago |
| Sean Parish | Latham & Watkins LLP | Associate | corporate | Chicago |
| Lucy Chauvin | Latham & Watkins LLP | Associate | corporate | Chicago |
| Brian Baloun | Latham & Watkins LLP | Associate | corporate | Chicago |
| Chelsea Carlson | Latham & Watkins LLP | Associate | corporate | Chicago |
| Katharine Moir | Latham & Watkins LLP | Partner | tax | Bay Area |
| Derek Gumm | Latham & Watkins LLP | Associate | tax | Not stated |
| Liz Richards | Latham & Watkins LLP | Partner | healthcare regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Counsel | healthcare regulatory | Bay Area |
| Jekkie Kim | Latham & Watkins LLP | Partner | intellectual property | Bay Area |
| Judith Hasko | Latham & Watkins LLP | Partner | intellectual property | Bay Area |
| Katherine Parsons-Reponte | Latham & Watkins LLP | Associate | intellectual property | San Diego |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy | Bay Area |
| Mandy Reeves | Latham & Watkins LLP | Partner | antitrust | Washington, D.C. |
| Josh Holian | Latham & Watkins LLP | Partner | antitrust | Bay Area |
| Julia Thompson | Latham & Watkins LLP | Partner | capital markets | Washington, D.C. |
| Shagufa Hossain | Latham & Watkins LLP | Partner | capital markets | Washington, D.C. |
| Kaan Ulgen | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Gabbi Blum | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Lilian Wang | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Jay Metz | Latham & Watkins LLP | Partner | benefits | Bay Area |
| Eric Green | Latham & Watkins LLP | Associate | trade controls | Washington, D.C. |
| Matt Salerno | Latham & Watkins LLP | Partner | FCPA | New York |
| Dean Baxtresser | Latham & Watkins LLP | Partner | government contracts | Washington, D.C. |
24 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 1.35bn (US$1.35 billion)
- What the figure measures
- Total transaction value
- Client
- Imago BioSciencesSell-side
- Counterparties
- Merck (Buy-side)